Clinical Trials Logo
  1. Home
  2. Bile Acid Malabsorption
  3. NCT03059537

Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea — VABAD  

Bile Acid Malabsorption Clinical Trial

Official title:
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea

Clinical Trial Summary

This study aims to validate a possible diagnostic test for bile acid diarrhoea prospectively compared to the SeHCAT scintigraphy. Fasting participants are given a standard meal and 1,250 mg chenodeoxycholic acid. The investigators measure fasting FGF19, bile acids species including 7-alpha-CHO and serial blood samples after the stimulation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03059537
Study type Interventional
Source Zealand University Hospital
Contact
Status Completed
Phase Phase 4
Start date March 13, 2017
Completion date November 27, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03876717 - Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea Phase 4
Terminated NCT01203254 - Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease Phase 4
Completed NCT02628626 - A Study of Colesevelam in Fecal Incontinence Phase 3
Completed NCT03955575 - Treatment of Bile Acid Malabsorption With Liraglutide Phase 4
Completed NCT02078856 - Double-blind, Randomised Study of A3384 in BAM/BAD Phase 2
Completed NCT03168555 - Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy Phase 4
Recruiting NCT05245357 - Impact of Foods on Bile Acids, Metabolites, and Inflammation N/A
Completed NCT03270085 - Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption Phase 2
Completed NCT05130047 - Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) Phase 2